Delivery Order SPE2DB20D3103-SPE2DB23FP5B3

Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-count capsules of 40 mg Omeprazole delayed-release medication. The contract has a total ceiling value of $3,703.50 and a completion date of June 4, 2024. It is a firm-fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,569.01, is for the delivery of Omeprazole DR 20 mg capsules in quantities of 1,000. It is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through June 2024. The contract was not designated with any set-aside requirements, indicating open competition. As a key vendor for...
This federal contract award is for the delivery of 1,000 Omeprazole DR 20 mg capsules to the Defense Logistics Agency (DLA). The $2,702.86 firm fixed-price delivery order contract has an ultimate completion date of April 30, 2024 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,564,083,797 capsules of Omeprazole DR 20 mg to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,822.24 and a period of performance through March 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 1,000 capsules of 40 mg Omeprazole DR for $6,277.53. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,213.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order to supply 4,567,154,263 units of Omeprazole DR 20 mg capsules. The contract has a completion date of February 5, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,105.22, is for the supply of 40 milligram omeprazole delayed-release capsules in quantities of 500 per bottle. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.85 Firm Fixed Price Delivery Order is for the supply of 500 units of Omeprazole DR 40 mg capsules, with a period of performance through August 18, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, providing a comprehensive...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for $3,028.57 to supply 500 units of Omeprazole delayed-release 40 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of July 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Omeprazole 20mg tablets in 1,000 count quantities. It is a firm-fixed price contract with a ceiling value of $21,370.61 and a period of performance through January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP5B3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Omeprazole DR 20 mg capsules. The contract is valued at $1,547.40 and has an ultimate completion date of August 28, 2023. It is a firm fixed-price contract, and no set-aside designation was used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 9:42 AM